Nature Communications (Oct 2021)

SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon

  • Kene Nwosu,
  • Joseph Fokam,
  • Franck Wanda,
  • Lucien Mama,
  • Erol Orel,
  • Nicolas Ray,
  • Jeanine Meke,
  • Armel Tassegning,
  • Desire Takou,
  • Eric Mimbe,
  • Beat Stoll,
  • Josselin Guillebert,
  • Eric Comte,
  • Olivia Keiser,
  • Laura Ciaffi

DOI
https://doi.org/10.1038/s41467-021-25946-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

Many African countries have reported relatively low numbers of COVID-19 cases but the true scale of the epidemic is unclear. Here, the authors conduct a population-based survey in a province of Cameroon and estimate 29% seroprevlance, >300 fold higher than the nationwide attack rate implied by case counts.